These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4381938)

  • 1. Stability of erythrocytic reduced glutathione and nicotinadenine dinucleotide phosphate in HbE-thalassaemia disease.
    Swarup S; Ghosh SK; Chatterjea JB
    Experientia; 1966 Sep; 22(9):580-1. PubMed ID: 4381938
    [No Abstract]   [Full Text] [Related]  

  • 2. ERYTHROCYTIC REDUCED GLUTATHIONE (GSH) AND GLUCOSE 6-PHOSPHATE DEHYDROGENASE (G-6-PD) ACTIVTY IN THALASSAEMIA TRAIT AND HB. E-TRAIT.
    SWARUP S; GHOSH SK; CHATTERJEA JB
    Bull Calcutta Sch Trop Med; 1963 Apr; 11():48-9. PubMed ID: 14299484
    [No Abstract]   [Full Text] [Related]  

  • 3. ERYTHROCYTE ENZYMES IN THALASSAEMIA.
    SWARUP S
    J Assoc Physicians India; 1963 Nov; 11():917-22. PubMed ID: 14077377
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced oxidative denaturation of hemoglobin.
    Nagel RL; Ranney HM
    Semin Hematol; 1973 Oct; 10(4):269-78. PubMed ID: 4610751
    [No Abstract]   [Full Text] [Related]  

  • 5. METHAEMOGLOBIN LEVEL AND ITS RELATION TO THE STABILITY OF ERYTHROCYTIC REDUCED GLUTATHIONE IN THALASSAEMIA SYNDROME.
    SWARUP S; GHOSH SK; CHATTERJEA JB
    Indian J Med Res; 1964 Mar; 52():273-8. PubMed ID: 14134590
    [No Abstract]   [Full Text] [Related]  

  • 6. ERYTHROCYTIC GLUTATHIONE REDUCTASE ACTIVITY IN HB. E-THALASSAEMIA DISEASE.
    SWARUP S; GHOSH SK; CHATTERJEA JB
    J Assoc Physicians India; 1965 Jan; 13():43-6. PubMed ID: 14257578
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular restraint: a new basis for the limitation in response to oxidative stress in human erythrocytes containing low-activity variants of glucose-6-phosphate dehydrogenase.
    Gaetani GD; Parker JC; Kirkman HN
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3584-7. PubMed ID: 4154443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual test for erythrocytic glucose-6-phosphate dehydrogenase, 6-phosphogluconic dehydrogenase, and glutathione reductase deficiencies.
    Frischer H; Carson PE; Bowman JE; Rieckmann KH
    J Lab Clin Med; 1973 Apr; 81(4):613-24. PubMed ID: 4144490
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of mercaptoethylamine on oxidation-reduction status of NADP in the spleen and the enhancement by cystamine of the activity of the system: glucose-6-phosphate dehydrogenase--glutathione reductase].
    Bitny-Szlachto S
    Acta Pol Pharm; 1972; 29(2):201-6. PubMed ID: 4403999
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of co-operation of commercial NADP+ and the coenzyme extracted from liver and spleen in the recycling system: glucose-6-phosphate dehydrogenase--glutathione reductase.
    Bitny-Szlachto S
    Acta Pol Pharm; 1978; 35(1):117-21. PubMed ID: 25561
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological modification of glutathione and NADP+ reduction.
    Gorodischer R; Moses SW; Bashan N
    Adv Exp Med Biol; 1972; 27():273-80. PubMed ID: 4155223
    [No Abstract]   [Full Text] [Related]  

  • 12. Glutathione and NADP linked enzymes in human senile cataract.
    Friedburg D; Manthey KF
    Exp Eye Res; 1973 Feb; 15(2):173-7. PubMed ID: 4692229
    [No Abstract]   [Full Text] [Related]  

  • 13. Assays of tissual NADP by means of the recycling system composed of isocitrate dehydrogenase and glutathione reductase.
    Bitny-Szlachto S
    Acta Pol Pharm; 1973; 30(1):103-4. PubMed ID: 4144437
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucose-6-phosphate dehydrogenase activity and NADPH/NADP+ ratio in liver and pancreas are dependent on the severity of hyperglycemia in rat.
    Díaz-Flores M; Ibáñez-Hernández MA; Galván RE; Gutiérrez M; Durán-Reyes G; Medina-Navarro R; Pascoe-Lira D; Ortega-Camarillo C; Vilar-Rojas C; Cruz M; Baiza-Gutman LA
    Life Sci; 2006 Apr; 78(22):2601-7. PubMed ID: 16325866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enzymatic defects of erythrocytes and hemolysis in the newborn].
    Vetrella M; Pierro M
    Pediatria (Napoli); 1971 Dec; 79(4):517-26. PubMed ID: 4401200
    [No Abstract]   [Full Text] [Related]  

  • 16. Inborn defects in the antioxidant systems of human red blood cells.
    van Zwieten R; Verhoeven AJ; Roos D
    Free Radic Biol Med; 2014 Feb; 67():377-86. PubMed ID: 24316370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Favism, hemoglobin H, alpha-thalassemia and hemoglobinopathy in various Sardinian families. Studies on glucose-6-phosphate dehydrogenase].
    Pabis A; Alessio L; Fiorelli G; Sulis E; Dioguardi N
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(1):56-60. PubMed ID: 4180962
    [No Abstract]   [Full Text] [Related]  

  • 18. Early changes in hepatic redox homeostasis following treatment with a single dose of valproic acid.
    Cotariu D; Evans S; Zaidman JL; Marcus O
    Biochem Pharmacol; 1990 Aug; 40(3):589-93. PubMed ID: 2116802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythocyte destruction and hemoglobin catabolism.
    Bunn HF
    Semin Hematol; 1972 Jan; 9(1):3-17. PubMed ID: 4553045
    [No Abstract]   [Full Text] [Related]  

  • 20. ERYTHROCYTIC GLUTATHIONE REDUCTASE ACTIVITY IN HB. E-THALASSAEMIA DISEASE.
    SWARUP S; GHOSH SK; CHATTERJEA JB
    Bull Calcutta Sch Trop Med; 1963 Jul; 11():100-1. PubMed ID: 14068648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.